1. Phase III PAOLA-1/ENGOT-ov25 trial: olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer treated with platinum-based chemotherapy plus bevacizumab. (1st November 2019) Authors: Harter, P; Mouret-Reynier, MA; Pignata, S; Cropet, C; González-Martin, A; Bogner, G; Fujiwara, K; Vergote, I; Colombo, N; Mäenpää, J; Floquet, A; El-Balat, A; Lorusso, D; Guerra Alia, EM; Fabbro, M; Schmalfeldt, B; Hardy Blessard, AC; Runnebaum, I; Pujade-Lauraine, E; Ray-Coquard, I Journal: International journal of gynecological cancer Issue: Volume 29(2019)Supplement 4 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗